Bottom line
QAAHBX vs SCHLX: the short answer
QAAHBX (T. Rowe Price Health Sciences Portfolio) and SCHLX (DWS Health and Wellness Fund) are both etfs.
But QAAHBX is far broader, holding 277 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.
SCHLX is cheaper at 1.06% vs 1.11% — a difference of $5.00 a year per $10,000 invested.
Updated Nov 19, 2026
QAAHBX vs SCHLX side by side
| QAAHBX | SCHLX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | T. Rowe Price | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.11% | 1.06% |
| Annual cost per $10k | $111 | $106 |
| 10-yr cost on $10k (prospectus) | $1,352 | $1,294 |
| Max front load | None | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +17.8% | — |
| 5-yr return (annualized) | +3.9% | — |
| 10-yr return (annualized) | +8.7% | — |
| Best quarter | +23.4% | — |
| Worst quarter | −15.8% | — |
| Net assets (fund) | $751.7M | $231.8M |
| Number of holdings | 277 | 65 |
| Portfolio turnover | 65% | 2% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
15 of QAAHBX's top 25 holdings also appear in SCHLX's top 25.
| Holding | QAAHBX | SCHLX |
|---|---|---|
| Eli Lilly & Co | 14.06% | 13.85% |
| Johnson & Johnson | 6.64% | 6.19% |
| Unitedhealth Group Inc | 5.88% | 5.73% |
| Abbvie Inc | 5.12% | 4.90% |
| Merck & Co. Inc. | 4.00% | 4.85% |
| Gilead Sciences Inc | 2.79% | 2.78% |
| Thermo Fisher Scientific Inc | 2.53% | 3.46% |
| Vertex Pharmaceuticals Inc | 2.26% | 2.45% |
| Bristol-myers Squibb Co | 2.12% | 1.50% |
| Abbott Laboratories | 1.91% | 2.39% |
| Intuitive Surgical Inc | 1.89% | 2.69% |
| Amgen Inc | 1.80% | 2.88% |
| Stryker Corp | 1.78% | 2.61% |
| Danaher Corp | 1.44% | 2.13% |
| Cardinal Health Inc | 1.04% | 1.34% |
Source: SEC Form N-PORT
QAAHBX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between QAAHBX and SCHLX?
Which is cheaper, QAAHBX or SCHLX?
Should I own both QAAHBX and SCHLX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.